C14H15N5O6S2
Neat
413.43
178422-39-4; (2R, 5Z)-2-[(R)-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-carboxymethyl]-5-ethylidene-2H-1, 3-thiazine-4-carboxylic acid; 2H-1, 3-Thiazine-2-acetic acid, alpha-[[(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-4-carboxy-5-ethylidene-5, 6-dihydro-, [R-[R*, R*-(Z, Z)]]- (9CI); W7QZ9U2GYB; (Z)-2-((R)-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)(carboxy)methyl)-5-ethylidene-5, 6-dihydro-2H-1, 3-thiazine-4-carboxylic acid; Cefdinir Impurity H(Cefdinir Cp Impurity E); 2H-1, 3-Thiazine-2-acetic acid, alpha-[[(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-4-carboxy-5-ethylidene-5, 6-dihydro-, [R-[R*, R*-(Z and Z)]]-
(2R, 5Z)-2-[(R)-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-carboxymethyl]-5-ethylidene-2H-1 and 3-thiazine-4-carboxylic acid
InChI=1S/C14H15N5O6S2/c1-2-5-3-26-11(18-7(5)12(21)22)9(13(23)24)17-10(20)8(19-25)6-4-27-14(15)16-6/h2,4,9,11,25H,3H2,1H3,(H2,15,16)(H,17,20)(H,21,22)(H,23,24)/b5-2+,19-8-/t9-,11+/m0/s1